Self-management for bronchiectasis.

Area of Science:

• Respiratory Medicine
• Clinical Trials
• Evidence-Based Practice

Background:

• Bronchiectasis is a chronic respiratory condition with increasing diagnoses, leading to significant patient and healthcare burdens.
• Effective management aims to reduce exacerbations and improve quality of life.
• Self-management interventions are recognized as a research priority for bronchiectasis.

Purpose of the Study:

• To evaluate the efficacy, cost-effectiveness, and adverse effects of self-management interventions in non-cystic fibrosis bronchiectasis.
• To assess the impact on adults and children with the condition.

Main Methods:

• Systematic review of randomized controlled trials (RCTs) up to December 2017.
• Included interventions with at least two elements: patient education, airway clearance, medication adherence, exercise, or action plans.
• Two review authors independently screened studies, extracted data, and assessed risk of bias.

Main Results:

• Two RCTs with 84 adults were included; no studies involved children.
• No clear evidence of benefit for health-related quality of life or exacerbation frequency.
• Limited data on serious adverse events, with one study noting more deaths in the intervention group.
• Very low-quality evidence indicated no benefit for hospital admissions or lung function (FEV1).

Conclusions:

• Insufficient evidence exists to confirm the benefits of self-management interventions for bronchiectasis.
• Current international guidelines recommending self-management should be followed in the absence of high-quality evidence.
• Future research needs to clearly define interventions, measure clinically important outcomes, and include pediatric populations.